The company’s key therapeutic segments namely Anti-malaria, Anti-infective and CNS have witnessed de-growth in the last few months. As a result, we now estimate Ipca’s highmargin domestic formulation business to grow below industry average …
Henan Kangtai Pharmaceutical Co., Ltd.
Norfloxacin|Norfloxacin HCL|Norfloxacin Nicotinate|Norfloxacin Lactate|Pefloxacin Mesylate|Mitomycin C|